Search clinical trials for: ADT (androgen deprivation therapy) (i.e. leuprolide) plus an androgen receptor inhibitor (i.e. bical
Total 31 results
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Prostate Carcinoma Metastatic to the BoneUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm in Lymph Node | Prostate Ductal Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Prostate Small Cell Neuroendocrine Carcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
David VanderWeeleTerminatedCastrate Resistant Prostate CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsCompletedProstate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedStage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States
-
Case Comprehensive Cancer CenterNational Institutes of Health (NIH)RecruitingProstate Cancer | Malignant Neoplasm of Prostate | Secondary Malignant Neoplasm of ProstateUnited States
-
University of MiamiRecruitingProstate Cancer | Prostate Adenocarcinoma | Hormone Sensitive Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterRecruitingProstate Cancer | Oligometastatic Disease | Castrate Sensitive Prostate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbActive, not recruitingProstate Cancer | Prostate DiseaseUnited States
-
Zin W MyintMerck Sharp & Dohme LLCRecruiting
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
University of Maryland, BaltimoreJanssen Scientific Affairs, LLCRecruitingProstate Cancer | Oligometastatic DiseaseUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerChina
-
Daniel George, MDMerck Sharp & Dohme LLCNot yet recruiting
-
M.D. Anderson Cancer CenterRecruitingProstate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer CenterNot yet recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
-
OHSU Knight Cancer InstituteJanssen Scientific Affairs, LLC; Oregon Health and Science UniversityActive, not recruitingMetastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate CarcinomaUnited States
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsCanada, France, Poland, Ukraine, United Kingdom, China, Belgium, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, Germany, Malaysia, Romania, South Africa, Turkey, Korea, Republic of, Japan, Australia, Netherlands, Sweden, New Zealand and more
-
Janssen Research & Development, LLCCompleted
-
Spanish Oncology Genito-Urinary GroupBristol-Myers Squibb; Syntax for Science, S.LActive, not recruitingMetastatic Hormone-sensitive Prostate CancerSpain
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma in the Soft Tissue | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States, Puerto Rico
-
Fudan UniversityActive, not recruitingNeoadjuvant Therapy | High-risk Prostate CancerChina
-
Lawrence FongMerck Sharp & Dohme LLC; Prostate Cancer Foundation; TriSalus Life Sciences,...Active, not recruitingProstatic NeoplasmsUnited States
-
Xiao X. Wei, MDBristol-Myers SquibbActive, not recruitingProstate Adenocarcinoma | Hormone Sensitive Prostate Cancer | Metastasis Prostate AdenocarcinomaUnited States
-
University of UtahTerminatedStage IV Prostate Cancer | Metastatic Prostatic Adenocarcinoma | Castration-Sensitive Prostate Carcinoma | Stage IVA Prostate Cancer | Stage IVB Prostate CancerUnited States
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NVNot yet recruiting
-
National Cancer Institute (NCI)CompletedProstatic Neoplasms | Prostate Cancer | Neoplasm, Prostate | Neoplasm,ProstaticUnited States
-
Medical Research CouncilActive, not recruitingProstate CancerUnited Kingdom, Switzerland
-
University of CagliariNot yet recruitingQuality of Life | Endometriosis | AmenorrheaItaly
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditionsUnited States, Puerto Rico